Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析

◆英語タイトル:Antares Pharma Inc (ATRS) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1334
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Antares Pharma Inc (ATRS) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Antares Pharma Inc (Antares Pharma) is a specialty pharmaceutical company that develops, manufactures, and commercializes self-administered parenteral pharmaceutical products and technologies. The company’s portfolio encompasses novel therapeutic products for the treatment of polyarticular juvenile idiopathic arthritis, adults with severe rheumatoid arthritis, severe recalcitrant psoriasis, migraine and cluster headache, and to reduce the risk of preterm birth in pregnant women. It caters its subcutaneous injection technology platforms to both generic and branded injectables. Antares Pharma’s injectables are available in disposable multi-dose pen injectors and unit dose containers. The company employs drug delivery systems to advance drug compounds and drug delivery methods. It also focuses on product development programs in partnership with various leading pharmaceutical companies including Teva and AMAG. The company has a presence in the US and Switzerland. Antares Pharma is headquartered in Ewing, New Jersey, the US.

Antares Pharma Inc Key Recent Developments

Mar 03,2020: Antares Pharma reports fourth quarter and full year 2019 operating and financial results
Feb 25,2020: Antares Pharma To Report Fourth Quarter And Full Year 2019 Financial And Operating Results
Jan 27,2020: Antares Pharma announces full-year 2020 net revenue guidance range of $135 to $155 million

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Antares Pharma Inc – Key Facts
Antares Pharma Inc – Key Employees
Antares Pharma Inc – Key Employee Biographies
Antares Pharma Inc – Major Products and Services
Antares Pharma Inc – History
Antares Pharma Inc – Company Statement
Antares Pharma Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Antares Pharma Inc – Business Description
Business Segment: Licensing and Development
Performance
Business Segment: Product Sales
Performance
Business Segment: Royalties
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Other
Performance
Geographical Segment: The US
Performance
R&D Overview
Antares Pharma Inc – Corporate Strategy
Antares Pharma Inc – SWOT Analysis
SWOT Analysis – Overview
Antares Pharma Inc – Strengths
Antares Pharma Inc – Weaknesses
Antares Pharma Inc – Opportunities
Antares Pharma Inc – Threats
Antares Pharma Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Antares Pharma Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 03, 2020: Antares Pharma reports fourth quarter and full year 2019 operating and financial results
Jan 27, 2020: Antares Pharma announces full-year 2020 net revenue guidance range of $135 to $155 million
Dec 10, 2019: Antares Pharma appoints Edward Tykot senior vice president, corporate development
Nov 20, 2019: Idorsia and Antares partner on auto-injector for AMI drug selatogrel
Nov 05, 2019: Antares Pharma reports third quarter 2019 operating and financial results
Oct 24, 2019: Antares Pharma announces two poster presentations at the 2019 Sexual Medicine Society Scientific Annual Meeting
Aug 06, 2019: Antares Pharma reports second quarter 2019 operating and financial results
Jun 27, 2019: Antares Pharma announces amendment to existing loan and security agreement with Hercules Capital
May 02, 2019: Antares Pharma reports first quarter 2019 operating and financial results
Mar 04, 2019: Antares Pharma announces board changes
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Antares Pharma Inc, Key Facts
Antares Pharma Inc, Key Employees
Antares Pharma Inc, Key Employee Biographies
Antares Pharma Inc, Major Products and Services
Antares Pharma Inc, History
Antares Pharma Inc, Other Locations
Antares Pharma Inc, Subsidiaries
Antares Pharma Inc, Key Competitors
Antares Pharma Inc, Ratios based on current share price
Antares Pharma Inc, Annual Ratios
Antares Pharma Inc, Annual Ratios (Cont...1)
Antares Pharma Inc, Interim Ratios
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Antares Pharma Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Antares Pharma Inc, Performance Chart (2015 - 2019)
Antares Pharma Inc, Ratio Charts
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Antares Pharma Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Antares Pharma Inc (ATRS):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Lexmark International Inc:企業の戦略的SWOT分析
    Lexmark International Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Tyson Foods Inc:企業の戦略・SWOT・財務情報
    Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report Summary Tyson Foods Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Safaricom Ltd:企業の戦略・SWOT・財務分析
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Air Mauritius Ltd.:企業の戦略・SWOT・財務情報
    Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report Summary Air Mauritius Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Cleveland-Cliffs Inc:企業のM&A・事業提携・投資動向
    Cleveland-Cliffs Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Cleveland-Cliffs Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Piraeus Bank SA:企業の戦略・SWOT・財務情報
    Piraeus Bank SA - Strategy, SWOT and Corporate Finance Report Summary Piraeus Bank SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • The Jackson Laboratory-製薬・医療分野:企業M&A・提携分析
    Summary The Jackson Laboratory (JAX) is a nonprofit biomedical research institution that offers genomic solutions. The institution offers services in the therapeutic areas of cardiovascular, metabolic diseases, oncology, rare diseases, and neurobiology. It offers breeding and rederivation services, …
  • Northern Power Systems Corp (NPS):企業の財務・戦略的SWOT分析
    Summary Northern Power Systems Corp (NPS), formerly Mira III Acquisition Corp is a renewable energy company that offers engineering solutions to energy sector. The company's products comprise wind turbines, power converters, microgrids, power technology products and others. It offers services such a …
  • C’Bon Cosmetics Co Ltd:企業の戦略・SWOT・財務情報
    C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report Summary C'Bon Cosmetics Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Fairfax Financial Holdings Limited:企業のM&A・事業提携・投資動向
    Fairfax Financial Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Fairfax Financial Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Rallye SA:戦略・SWOT・企業財務分析
    Rallye SA - Strategy, SWOT and Corporate Finance Report Summary Rallye SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • Treeway BV:製薬・医療:M&Aディール及び事業提携情報
    Summary Treeway BV (Treeway) is a biotechnology company that develops drugs for the treatment of amyotrophic lateral sclerosis (ALS). The company provides pipeline products such as TW001, an oral formulation of edaravone, which protects against neuronal apoptosis and oxidative stress. It offers prod …
  • Akebia Therapeutics Inc (AKBA):企業の財務・戦略的SWOT分析
    Summary Akebia Therapeutics Inc (Akebia Therapeutics) is a biopharmaceutical company focused on the development and commercialization of novel therapeutics based on hypoxia inducible factor for patients with kidney disease and other metabolic disorders. Its lead product candidate vadadustat is a HIF …
  • Global Bioenergies SA (ALGBE):企業の財務・戦略的SWOT分析
    Global Bioenergies SA (ALGBE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Fresenius Kabi USA LLC:企業の戦略的SWOT分析
    Fresenius Kabi USA LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Molnlycke Health Care AB:医療機器:M&Aディール及び事業提携情報
    Summary Molnlycke Health Care AB (Molnlycke), a subsidiary of Investor AB, is a medical device company. The company manufactures and markets single-use surgical and wound care products. It offers a range of surgical and wound care products; infection prevention solutions; prevention and treatment so …
  • Hanger, Inc. (HNGR)
    Hanger, Inc. (HNGR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • PACCAR Inc (PCAR):企業の財務・戦略的SWOT分析
    PACCAR Inc (PCAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Kuwait Petroleum Corp:企業の戦略的SWOT分析
    Kuwait Petroleum Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Silver Lake Resources Limited:企業の戦略・SWOT・財務情報
    Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report Summary Silver Lake Resources Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆